Abstract:This systematic review addresses the complex nature of Panic Disorder (PD), characterized by recurrent episodes of acute fear, with a focus on updating and consolidating knowledge regarding neurochemical, genetic, and epigenetic factors associated with PD. Utilizing the PRISMA methodology, 33 original peer-reviewed studies were identified, comprising 6 studies related to human neurochemicals, 10 related to human genetic or epigenetic alterations, and 17 animal studies. The review reveals patterns of altered expression in various biological systems, including neurotransmission, the Hypothalamic-Pituitary-Adrenal (HPA) axis, neuroplasticity, and genetic and epigenetic factors leading to neuroanatomical modifications. Noteworthy findings include lower receptor binding of GABAA and serotonin neurotransmitters in the amygdala. The involvement of orexin (ORX) neurons in the dorsomedial/perifornical region in triggering panic reactions is highlighted, with systemic ORX-1 receptor antagonists blocking panic responses. Elevated Interleukin 6 and leptin levels in PD patients suggest potential connections between stress-induced inflammatory changes and PD. Brain-derived neurotrophic factor (BDNF) and tyrosine receptor kinase B (TrkB) signaling are implicated in panic-like responses, particularly in the dorsal periaqueductal gray (dPAG), where BDNF's panicolytic-like effects operate through GABAA-dependent mechanisms. GABAergic neurons' inhibitory influence on dorsomedial and posterior hypothalamus nuclei is identified, potentially reducing the excitability of neurons involved in panic-like responses. The dorsomedial hypothalamus (DMH) is highlighted as a specific hypothalamic nucleus relevant to the genesis and maintenance of panic disorder. Altered brain lactate and glutamate concentrations, along with identified genetic polymorphisms linked to PD, further contribute to the intricate neurochemical landscape associated with the disorder. The review underscores the potential impact of neurochemical, genetic, and epigenetic factors on the development and expression of PD. The comprehensive insights provided by this systematic review contribute to advancing our understanding of the multifaceted nature of Panic Disorder and pave the way for targeted therapeutic strategies.

Anxiety and the brain: Neuropeptides as emerging factors

Protective Role and Functional Engineering of Neuropeptides in Depression and Anxiety: An Overview

Combinational Approaches Targeting Various Aspects Involved in Intestinal Barrier Dysfunction-Induced Anxiety

Neurabin in the Anterior Cingulate Cortex Regulates Anxiety-Like Behavior in Adult Mice

Neural circuit basis of pathological anxiety

Genetic-epigenetic-neuropeptide associations in mood and anxiety disorders: Toward personalized medicine

Prenatal Stress, Anxiety and Depression: a Mechanism Involving CRH Peptide Family.

Pathophysiological and therapeutic implications of neuropeptide S system in neurological disorders

Advances in neuroscience research and big data's analysis on anxiety disorder

Recent advances in anxiety disorders: Focus on animal models and pathological mechanisms

Hindbrain Networks: Exploring the Hidden Anxiety Circuits in Rodents

Neuropeptide Y and its receptors as potential therapeutic drug targets

Hippocampus: Molecular, Cellular, and Circuit Features in Anxiety

Translational approaches to anxiety: focus on genetics, fear extinction and brain imaging

Neurochemical and genetic factors in panic disorder: a systematic review

Neuropeptide Y, calcitonin gene-related peptide, and neurokinin A in brain regions of HAB rats correlate with anxiety-like behaviours

Opioids and anxiety

Prefrontal Cortical Control of Anxiety: Recent Advances

Physiological and Therapeutic Roles of Neuropeptide Y on Biological Functions

Neurobiological links between stress and anxiety

Neuroanatomical Correlates of Anxiety Disorders and Their Implications in Manifestations of Cognitive and Behavioral Symptoms